QuidelOrtho (QDEL) Cash & Current Investments (2021 - 2026)
QuidelOrtho (QDEL) posted Cash & Current Investments of $140.4 million for Q1 2026, down 17.31% sequentially from $169.8 million in Q4 2025, and up 10.46% YoY from $127.1 million in Q1 2025.
QuidelOrtho (QDEL) Cash & Current Investments (2021 - 2026) Analysis & Trends
QuidelOrtho has reported Cash & Current Investments for 6 years, with the latest figure at $140.4 million in Q1 2026.
- Quarterly Cash & Current Investments rose 10.46% year-over-year to $140.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $140.4 million (up 10.46% YoY) and the FY2025 annual result came in at $169.8 million, up 72.74% from the prior year.
- Cash & Current Investments retreated to $140.4 million in Q1 2026 per QDEL's latest filing, from $169.8 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.3 billion in Q2 2022 and troughed at $79.0 million in Q1 2024.
- A 5-year average of $291.6 million and a median of $168.8 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 80.14% in 2024, then soared 72.74% in 2025.
- Over 5 years, Cash & Current Investments stood at $265.0 million in 2022, then slumped by 36.64% to $167.9 million in 2023, then plunged by 41.45% to $98.3 million in 2024, then jumped by 72.74% to $169.8 million in 2025, then fell by 17.31% to $140.4 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $140.4 million, $169.8 million, and $98.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | 123.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 123.40 Mn |
| Mar 29, 2026 | 140.40 Mn |
| Dec 28, 2025 | 169.80 Mn |
| Sep 28, 2025 | 98.10 Mn |
| Jun 29, 2025 | 151.70 Mn |
| Mar 30, 2025 | 127.10 Mn |
| Dec 29, 2024 | 98.30 Mn |
| Sep 29, 2024 | 144.00 Mn |
| Jun 30, 2024 | 107.50 Mn |
| Mar 31, 2024 | 79.00 Mn |
| Dec 31, 2023 | 167.90 Mn |
| Oct 1, 2023 | 193.80 Mn |
| Jul 2, 2023 | 224.70 Mn |
| Apr 2, 2023 | 397.70 Mn |
| Jan 1, 2023 | 346.00 Mn |
| Oct 2, 2022 | 265.00 Mn |
| Jul 3, 2022 | 433.10 Mn |
| Apr 3, 2022 | 1.28 Bn |
| Jan 2, 2022 | 828.50 Mn |
| Oct 3, 2021 | 578.40 Mn |